Systemic Lupus Erythematosus
Henry Ford Health System – Rheumatology Primary Coordinator: Jenna Hudy 313-916-9328 Indication: Systemic Lupus Erythematosus Enrollment Status: Open Protocol: ZB012-02-001 Drug: Oblexelimab Sponsor: Zenas BioPharma Description: A phase 2, multicenter, randomized, double-blind, placebo-controlled study to […]
Systemic Lupus Erythematosus
Clinical Research Institute of Michigan – Shores Rheumatology Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201 Indication: Systemic Lupus Erythematosus Enrollment Status: Open Protocol: M23-699 Drug: Upadacitinib Sponsor: Abbvie Description: A […]
Systemic Lupus Erythematosus
Henry Ford Health System – Rheumatology Primary Coordinator: Jenna Hudy 313-916-9328 Indication: Systemic Lupus Erythematosus Enrollment Status: Open Protocol: CVAY736F12301 Drug: Ianalumab Sponsor: Novartis Description: A randomized, double-blind, parallel group, placebo-controlled multicenter phase 3 study to […]